Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observation with or without antibiotics for uncomplicated acute appendicitis
2018-001578-71Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- Jun 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of piperacillin, tazobactam, ciprofloxacin and metronidazole in acute appendicitis (2 arms), sponsored by University of Gothenburg. Primary endpoint: Treatment failure. Started Jun 2018; status: completed.
02
Drugs
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2018-001578-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001578-71.